###begin article-title 0
ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 505 506 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The study was aimed to compare inflammatory parameters between carriers of apoE4 isoforms (apoE4/3, apoE4/2, and apoE4/4 phenotypes) and those of carrying apoE3 isoform without apoE4 isoform (apoE3/3 phenotypes and apoE2/3 phenotypes). The concentrations of serum hsCRP, sVCAM-1, sICAM-1, and sE-selectin were measured in 211 subjects from Finnish low-HDL families and in 157 normolipidemic subjects. The subjects with apoE4 isoform had lower concentrations of serum hsCRP both in low-HDL family members (p < 0.05) and in normolipidemic subjects (p < 0.01). The differences in serum CRP values remained significant after adjustment for age, BMI, smoking status, hypertension, gender, lipoprotein variables, and family number. We conclude that apoE phenotype has a strong influence on serum CRP values.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
A substantial body of evidence indicates, that low-grade inflammation in the vascular endothelium promotes atherogenesis [1, 2]. This is indirectly evidenced by the fact that several inflammatory markers are linked to an increased risk of atherosclerosis. High-sensitive CRP (hsCRP) has been reported to associate with an increased risk of myocardial infarction, stroke, sudden death from cardiac causes, and peripheral arterial disease [3]. In addition, hsCRP has been shown to predict the first cardiovascular event better than low-density lipoprotein cholesterol (LDL-C) [3].
###end p 4
###begin p 5
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
Recruitment of inflammatory cells from the circulation and their transendothelial migration is one of the earliest phases of atherogenesis [3]. Vascular endothelium expresses cellular adhesion molecules (CAMs) in response to several inflammatory stimuli [4]. The evidence for the role of CAMs in the pathogenesis of atherosclerosis has emerged from experimental studies which have demonstrated the focal expression of adhesion molecules in atherosclerotic plaques [4-6]. 
###end p 5
###begin p 6
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Different CAMs have various functions in the vasculature. Selectins and their ligands are involved in the first steps in leukocyte adhesion at sites of endothelial injury as they mediate the rolling and tethering of leukocytes in the vascular wall [1, 2]. Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) induce firm adhesion of inflammatory cells to the vascular surface [3]. Overall, both soluble ICAM-1 (sICAM-1) and soluble VCAM-1 (sVCAM-1) have been linked to increase risk of atherosclerosis [7-9].
###end p 6
###begin p 7
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 459 464 <span type="species:ncbi:9606">human</span>
Apolipoprotein E (apoE) is secreted from hepatocytes and macrophages. ApoE is transported in lipoproteins, and it regulates the hepatic uptake of remnant lipoproteins and facilitates cholesterol efflux from foam cells [10]. In addition, apoE has a central role in inflammation and in mediating the central nervous system response to injury [11-13]. There are three common ApoE isoforms, designated E2, E3, and E4, which are encoded for by distinct alleles on human chromosome 19. ApoE isoforms are distributed in six different phenotypes E2/2, E2/3, E3/3, E4/2, E4/3, and E4/4 [10]. The presence of E4 isoform is associated with coronary heart disease [14] and with the early onset of Alzheimer's disease [15].
###end p 7
###begin p 8
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 143 146 <span type="species:ncbi:9606">men</span>
###xml 214 217 <span type="species:ncbi:9606">men</span>
###xml 440 443 <span type="species:ncbi:9606">men</span>
###xml 448 453 <span type="species:ncbi:9606">women</span>
###xml 720 735 <span type="species:ncbi:10090">transgenic mice</span>
So far, there are sparse data on apoE polymorphism in relation to the parameters of inflammation. Manttari et al [16] showed that dyslipidemic men with E4/4, E4/3, and E4/2 phenotypes exhibit lower CRP values than men carrying other apoE phenotypes. In a recent report by Marz et al [17], carriers of apoE2 allele and apoE3/3 homozygotes had significantly higher CRP than individuals with the genotypes apoE3/4 and apoE4/4. In dyslipidemic men and women, C-reactive protein has been reported to be lower in subjects with one or two copies of E4 allele than in those with zero E4 allele [18]. Paradoxically, E4 allele has been associated with an enhanced inflammatory reaction after cardiopulmonary bypass [19]. In line, transgenic mice expressing the E4 allele had greater systemic and brain elevations of proinflammatory cytokines than E3 carriers [20].
###end p 8
###begin p 9
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
We hypothesize that the apoE phenotype, as a critical component in inflammatory processes, may influence the levels of inflammation markers. HDL has been demonstrated to exhibit antiinflammatory properties by inhibiting cytokine induced expression of adhesion molecules [21-23]. In contrast, acute inflammation process may decrease HDL concentration and thus compromise its antiatherogenic function [24, 25]. Interestingly, recycling of apoE is closely linked to HDL metabolism [26]. Therefore we studied the effects of apoE phenotype on the levels of CRP and sCAMs on a sample of Finnish low-HDL families and in normolipidemic subjects.
###end p 9
###begin title 10
SUBJECTS AND METHODS
###end title 10
###begin p 11
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1713 1715 1709 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 2115 2117 2111 2113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 2382 2383 2376 2377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 2433 2436 2427 2430 <mml:mi xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">log</mml:mi>
###xml 2436 2437 2430 2431 <mml:mo xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8289;</mml:mo>
###xml 2433 2437 2427 2431 <mml:mrow xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><mml:mi>log</mml:mi><mml:mo>&#8289;</mml:mo></mml:mrow>
###xml 2437 2439 2431 2433 <mml:mn xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">10</mml:mn>
###xml 2437 2439 2431 2433 <mml:mrow xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><mml:mn>10</mml:mn></mml:mrow>
###xml 2433 2439 2427 2433 <mml:msub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><mml:mrow><mml:mi>log</mml:mi><mml:mo>&#8289;</mml:mo></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub>
###xml 2433 2439 2427 2433 <mml:mrow xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><mml:msub><mml:mrow><mml:mi>log</mml:mi><mml:mo>&#8289;</mml:mo></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub></mml:mrow>
###xml 2433 2439 2427 2433 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="M1"><mml:mrow><mml:msub><mml:mrow><mml:mi>log</mml:mi><mml:mo>&#8289;</mml:mo></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math>
###xml 2471 2472 2465 2466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1117 1125 <span type="species:ncbi:9606">patients</span>
The study subjects were recruited according to the study protocol as reported previously [27]. To identify the low-HDL families, first degree relatives of the probands were examined. The family members were coded as affected if their HDL-C levels were below the 10th percentile cut-off levels. If at least two affected subjects were identified in the family, all available second-degree relatives and spouses were contacted and included in the study. The blood samples for the lipid and lipoprotein analysis were taken at the same visit as the inflammation parameters and therefore the lipid and lipoprotein values in this study represent the values of that visit, and not those of the screening visit. Altogether 211 low-HDL family members and 157 normolipidemic subjects had measures of their apoE phenotype, hsCRP, and sVCAM-1 concentrations. Seventeen low-HDL subjects had history of CHD. The normolipidemic group comprised healthy volunteers and normolipidemic spouses from the low-HDL families. They were required to have no signs of CHD or diabetes, and no lipid lowering medication. The smoking status of the patients was categorized into current smokers and nonsmokers (including exsmokers). Hypertension was defined as self-reported use of antihypertensive drugs, systolic blood pressure >/= 140 mmHg, or diastolic blood pressure >/= 90 mmHg. Estrogen use was defined as any means of estrogen administration (oral contraceptives, or oral or transdermal postmenopausal hormone replacement therapy). Venous blood samples were collected after overnight fasting. Serum was separated and used for the biochemical measurements. Lipid and lipoprotein measurements were done from serum as described previously [27]. Serum levels of sICAM-1, sVCAM-1, and sE-selectin were measured by using commercially available monoclonal antibody-based ELISAs (R & D Systems, Minneapolis, MN, USA). Serum highly sensitive CRP (hsCRP) was determined by a commercial kit from Medix Biochemica, Kauniainen, Finland. Subjects with CRP levels over 10 mg/l were excluded. ApoE phenotype was determined by the method of Havekes et al [28]. Statistical comparisons of clinical and biochemical parameters were performed with SPSS 11.0 for Windows (SPSS Inc., Chigaco, IL, USA). Data are expressed as mean +/- standard error of mean (SEM). Continuous variables were compared between two groups by Student t test. Variables with nonnormal distribution were log⁡10-transformed before comparison. P < .05 was considered to be significant (two-tailed). The frequency distribution between the groups was compared with the Chi-square test. The correlation coefficients between the biochemical and clinical characteristics were examined by Pearson's correlation for continuous variables. Multiple regression analysis was performed to determine the relative contribution of different variables to hsCRP and sVCAM-1 values. In the low-HDL group, the subjects came from 47 different families. Ten families had only one subject, and five families had 11-16 subjects. Because the subjects in the present cohort were not independent, we used the family number (which indicates belonging to a certain family) as a random variable. Family-number-adjusted residuals of log CRP and log VCAM were used in the multiple regression model for low-HDL family members. Since control subjects were not related, the family-number adjustment was performed only in the low-HDL group.
###end p 11
###begin title 12
RESULTS
###end title 12
###begin p 13
###xml 307 314 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
The effects of apoE phenotype was studied by dividing subjects into two subgroups (apoE groups): into the E3 group, which included E3/2 and E3/3 phenotypes, and into the E4 group which included E4/2, E4/3, and E4/4 phenotypes. Clinical and biochemical characteristics of the study subjects are presented in Table 1.
###end p 13
###begin p 14
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 522 523 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 600 607 600 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 763 764 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 776 777 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 793 800 793 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 895 896 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 943 944 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 954 961 954 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
Table 2 shows that serum hsCRP values were significantly lower in the E4 than in the E3 subgroup both in the low-HDL group (P < .01) and in the normolipidemic group (P < .05) after adjustment for age, BMI, serum apoA-I, apoA-II, apoB, HDL-C, LDL-C, triglycerides, smoking status, hypertension, and gender in normolipidemic subjects, and after additional adjustment for family number in the low-HDL group. The concentration of serum sVCAM-1 was significantly lower in the E4 group than in the E3 group in low-HDL subjects (P < .01) but the significance disappeared after adjustment for family number (Table 2). Multiple regression analysis revealed that apoE phenotype was a significant predictor of serum hsCRP values both in low-HDL and normolipidemic subjects (P = .023 and P = .011, resp) (Table 3). Estrogen used was also a strong predictor of serum hsCRP concentration in low-HDL subjects (P = .026) as well as in normolpidemic subjects (P = .036) (Table 3)
###end p 14
###begin title 15
DISCUSSION
###end title 15
###begin p 16
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 795 803 <span type="species:ncbi:9606">patients</span>
###xml 823 828 <span type="species:ncbi:9606">human</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
The major finding of the present study is that subjects presenting the apoE4 allele have decreased levels of serum hsCRP. This is an interesting observation, since ApoE plays a central role in inflammation and atherosclerosis. ApoE knockout mice are especially prone to atherosclerosis [10] and to die from lipopolysaccharide (LPS)-induced sepsis [11]. ApoE participates in cholesterol efflux, and has been observed to be recycled from triglyceride-rich lipoproteins into HDL-particles [10, 26]. In mice, exogenous apoE injection has been demonstrated to decrease the LPS-induced production of proinflammatory cytokines, probable by decreasing the release of cytokines from macrophages, which was accompanied by reduced mortality [11]. CRP and apoE concentrations are inversely related in obese patients [12]. In addition, human CRP transgene expression has been shown to cause accelerated atherosclerosis in apolipoprotein E-deficient mice [13]. Thus, according to these studies, the role of apoE in inflammation and atherosclerosis may be protective.
###end p 16
###begin p 17
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1250 1252 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1378 1380 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1430 1432 1430 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 326 341 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 761 764 <span type="species:ncbi:9606">men</span>
###xml 1097 1105 <span type="species:ncbi:9606">patients</span>
Despite the importance of apoE in the inflammatory process, only few studies have linked apoE polymorphisms to inflammatory parameters. In the central nervous system, apoE4 has been reported to be less effective than apoE3 or apoE2 at suppressing the activation of microglia in cell culture models of brain inflammation [29]. Transgenic mice expressing the apoE4 allele have significantly greater systemic and brain elevations of proinflammatory cytokines TNF-alpha and IL-6 as compared with their apoE3 counterparts [20]. In the present study, the hsCRP concentration was significantly lower in subjects exhibiting apoE4 allele than in those exhibiting other alleles. Likewise, Manttari and associates demonstrated, in a population of 179 dyslipidemic Finnish men, that subjects with apoE4/3 phenotype had lower mean CRP concentration than those with apoE3/3 phenotype [16]. In Japanese Americans, CRP values have been reported to be significantly higher in apoE2 carriers than in apoE3 or apoE4 carriers, and similar between apoE3 and apoE4 carriers [30]. In line with the Japanese data, German patients with or without coronary heart disease also showed higher CRP values in apoE2 carriers than in apoE3/4 heterozygotes or in apoE4/4 homozygotes [17]. However, CRP was also significantly higher in apoE3/3 homozygotes than in apoE3/4 heterozygotes or in apoE4/4 homozygotes [17]. Similarly, in the Cardiovascular Health Study [31], CRP values were lower in apoE4 positive than in apoE4 negative individuals independently of the amount of used alcohol. Thus, the present data extend these previous observations to a cohort of low-HDL family members as well as to normolipidemic subjects.
###end p 17
###begin p 18
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
The mechanisms behind low serum CRP values in apoE4 carriers in this study, and in previous works [16-18, 31] are unclear. Since apoE phenotype remained as a predictor of hsCRP in multiple regression model, the difference between apoE4 and apoE3 groups can not be explained by confounding factors, such as estrogen use. One explanation, originally suggested by Marz and associates [17], could be that the metabolism of CRP is related to mevalonate pathway. In carriers of apoE4, the mevalonate pathway may be down-regulated resulting in decreased CRP [17].
###end p 18
###begin p 19
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
The observed low serum CRP values in apoE4 carriers in the present study, and reportedly low CRP values in apoE4 carriers in previous works [16-18, 31], are perplexing findings since apoE4 allele is associated to an increased risk of atherosclerosis [14]. However, in the present study, the low-HDL family members within the E4 group had an atherogenic lipid profile: they had higher concentrations of apoB, a trend for higher serum triglycerides, and lower concentration of HDL-C as compared with the E3 group. Thus, the changes in lipoproteins rather than changes in inflammatory parameters may explain the atherogenity of apoE4 allele.
###end p 19
###begin p 20
We conclude that apoE phenotype has a strong influence on C-reactive protein. ApoE may be a double-faced protein having different actions in lipid metabolism and inflammation.
###end p 20
###begin title 21
ACKNOWLEDGMENTS
###end title 21
###begin p 22
We thank all the study subjects for participating in this study. Virve Naatti, Helina Perttunen-Nio, and Hannele Hilden are thanked for their excellent technical assistance. This work was supported by grants from the Finnish Cardiovascular Research Foundation, Special State Grants for health science research, The Finnish Medical Society Duodecim, The Sigrid Juselius Foundation, The International HDL Research Awards, The Paulo Foundation, Aarne Koskelo Foundation, Maud Kuistila Foundation, and The Biomedicum Helsinki Foundation.
###end p 22
###begin article-title 23
Atherosclerosis-an inflammatory disease
###end article-title 23
###begin article-title 24
Inflammation and atherosclerosis
###end article-title 24
###begin article-title 25
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
###end article-title 25
###begin article-title 26
Adhesion molecules and atherosclerosis
###end article-title 26
###begin article-title 27
###xml 82 87 <span type="species:ncbi:9606">human</span>
The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
###end article-title 27
###begin article-title 28
###xml 114 119 <span type="species:ncbi:9606">human</span>
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content
###end article-title 28
###begin article-title 29
Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The atherosclerosis risk in communities (ARIC) study
###end article-title 29
###begin article-title 30
###xml 130 133 <span type="species:ncbi:9606">men</span>
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
###end article-title 30
###begin article-title 31
Circulating cell adhesion molecules are correlated with ultrasound-based assesment of carotid atherosclerosis
###end article-title 31
###begin article-title 32
###xml 62 67 <span type="species:ncbi:9606">human</span>
Apolipoprotein E and atherosclerosis: insight from animal and human studies
###end article-title 32
###begin article-title 33
Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat Gram-negative sepsis
###end article-title 33
###begin article-title 34
Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential antiinflammatory role of apoE in vivo
###end article-title 34
###begin article-title 35
###xml 96 100 <span type="species:ncbi:10090">mice</span>
C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
###end article-title 35
###begin article-title 36
Meta-analysis: apolipoprotein E genotypes and risk of coronary heart disease
###end article-title 36
###begin article-title 37
Apolipoprotein E and Alzheimer's disease
###end article-title 37
###begin article-title 38
###xml 81 84 <span type="species:ncbi:9606">men</span>
Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle aged men
###end article-title 38
###begin article-title 39
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)
###end article-title 39
###begin article-title 40
New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals
###end article-title 40
###begin article-title 41
Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass
###end article-title 41
###begin article-title 42
ApoE genotype and an apoEmimetic peptide modify the systemic and central nervous system inflammatory response
###end article-title 42
###begin article-title 43
High-density lipoprotein inhibit cytokine-induced expression of endothelial cell adhesion molecule
###end article-title 43
###begin article-title 44
Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation
###end article-title 44
###begin article-title 45
Inhibition of VCAM-1 expression in endothelial cells by reconstituted high-density lipoproteins
###end article-title 45
###begin article-title 46
Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I
###end article-title 46
###begin article-title 47
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 148 163 <span type="species:ncbi:10090">transgenic mice</span>
Human secretory phospholipase A2 (sPLA2) mediates decreased plasma levels of HDL-cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice
###end article-title 47
###begin article-title 48
Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization
###end article-title 48
###begin article-title 49
A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families
###end article-title 49
###begin article-title 50
A rapid micromethod for apolipoprotein E phenotyping directly in serum
###end article-title 50
###begin article-title 51
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
###end article-title 51
###begin article-title 52
Heritability of Creactive protein and association with apolipoprotein E genotypes in Japanese Americans
###end article-title 52
###begin article-title 53
Alcohol consumption and inflammatory markers in older adults: the Cardiovascular Health Study
###end article-title 53
###begin title 54
Figures and Tables
###end title 54
###begin p 55
The clinical characteristics and lipid values of the study subjects.
###end p 55
###begin p 56
Data are expressed as means +/- SEMs.
###end p 56
###begin p 57
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 10 23 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 23 24 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
*P < .05, double daggerP < .06 after adjustment for smoking.
###end p 57
###begin p 58
The concentrations of hsCRP, sVCAM-1, sICAM-1, and sE-SELECTIN in Low-HDL subjects and normolipidemic subjects divided by apoE subgroups.
###end p 58
###begin p 59
###xml 40 41 38 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 50 51 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are expressed as means +/- SEMs. **P < .01; *P < .05 for the comparison with the E3 group after adjustment for age, gender, BMI, hypertension, smoking status, and lipoprotein variables; and family number in the low-HDL group.
###end p 59
###begin p 60
Multiple regression analysis of predictors of CRP values in low-HDL and normolipidemic subjects.
###end p 60
###begin p 61
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 35 36 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The adjusted multiple R2 is 0.202 (P < .001) for low-HDL subjects and 0.326 (P < .001) for normolipidemic subjects when all variables are included. The dependent variable in low-HDL family members is the family number adjusted residual of log CRP, and in normolipidemic subjects, the dependent variable is log CRP. Variables with skewed distribution were log-transformed before entering into the model.
###end p 61

